Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

Arialief is a nutritional supplement skillfully produced to target the root cause of sciatic nerve discomfort. It comb ...

Cannabidiol (CBD) holds great promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

Neuropathic pain is a severe clinical condition caused by damage to the nervous system. It often feels like a burning, ...

Researchers at Weill Cornell Medicine and the Burke Neurological Institute have made an exciting discovery—a new drug that ...

Groundbreaking research has transformed our understanding of acupuncture's role in treating sciatica, a debilitating ...

The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks ...

Neuropathic pain is nerve pain that occurs when your nervous system fails or gets damaged. According to studies, this pain can be felt differently from other kinds of pain. Hina Khan is battling with ...